ISBMT 2023

This presentation detailed the clinical outcomes and patient results following allogenic haematopoietic stem cell transplantation (HSCT) for lymphoma, based on a comprehensive review of single-center data. It emphasized the efficacy of the transplantation procedure, analyzing survival metrics, disease control, and the recovery process for patients who underwent this complex medical intervention.

The findings showcased the institution's experience and expertise in performing HSCT for lymphoma patients, serving as a platform for sharing successful methodologies. By reviewing the specific clinical data from this single-center experience, the study provided evidence-based insights into the success rates and long-term outcomes associated with allogenic stem cell transplantation for lymphoma management.

Upcoming Events